Testing an experimental drug for high cholesterol
Treatments studied
Part of Hormones & metabolism clinical trials.
This study tests an experimental drug called HRS-1301 to see if it safely lowers LDL ("bad") cholesterol in people with high cholesterol. It is for adults who either already have artery disease or are at higher risk for it.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be at least 18 years old.
- Your body mass index (BMI) must be 18 or higher.
- You must have either a history of artery disease (like heart attack or stroke) with LDL cholesterol at least 1.8 mmol/L, OR have intermediate/high risk for artery disease with LDL at least 2.6 mmol/L.
- You must agree to use effective birth control if you or your partner could become pregnant.
- You cannot have very high triglycerides (above 5.6 mmol/L) or certain other conditions (like recent heart event, severe heart failure, cancer within 5 years, or poorly controlled diabetes/high blood pressure).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new medication called SHR-1918 for people with high cholesterol who are already on statins. The goal is to see if it can further lower cholesterol and improve health.
This trial tests a new drug called HS-10582 in healthy people and those with slightly high LDL cholesterol (a type of cholesterol). The goal is to see if it is safe and how well your body handles it.
This trial tests a new medication (QLC7401) for people with high cholesterol that is not well controlled by their current treatment. It aims to see if the drug can help lower LDL-C (bad cholesterol) levels and reduce the risk of heart problems.
This trial tests an experimental drug, QLC7401, for people with high LDL cholesterol that hasn't lowered enough with current treatments. It aims to see if the drug can help reduce cholesterol levels in patients who are already on stable cholesterol medication.
This Phase 3 study tests whether JS002 alone can lower LDL “bad” cholesterol in people whose levels are still too high for their heart-risk level. It will also check how safe the treatment is, especially for heart and metabolic side effects.
This trial tests a new tablet, HRS-1301, to see how it is processed by the body in people with different levels of kidney function. It aims to help doctors understand dosing for patients with kidney impairment.
Hear when a new Hyperlipidemia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.